Fonar (FONR) Earns Media Impact Rating of 0.28

Media stories about Fonar (NASDAQ:FONR) have trended positive this week, according to Accern Sentiment Analysis. Accern identifies positive and negative media coverage by monitoring more than twenty million news and blog sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Fonar earned a daily sentiment score of 0.28 on Accern’s scale. Accern also assigned headlines about the medical equipment provider an impact score of 45.3094860802989 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the immediate future.

Fonar stock opened at $26.40 on Thursday. Fonar has a 52 week low of $17.20 and a 52 week high of $33.90. The stock has a market capitalization of $163.79, a price-to-earnings ratio of 9.10 and a beta of 2.36.

Fonar (NASDAQ:FONR) last issued its quarterly earnings results on Monday, February 12th. The medical equipment provider reported $0.70 earnings per share (EPS) for the quarter. Fonar had a return on equity of 23.26% and a net margin of 23.44%. The company had revenue of $20.17 million for the quarter.

In related news, Director Robert J. Janoff sold 1,000 shares of the firm’s stock in a transaction on Tuesday, February 20th. The stock was sold at an average price of $25.73, for a total transaction of $25,730.00. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Company insiders own 8.33% of the company’s stock.

TRADEMARK VIOLATION NOTICE: “Fonar (FONR) Earns Media Impact Rating of 0.28” was published by BBNS and is the property of of BBNS. If you are accessing this report on another site, it was illegally copied and republished in violation of US and international trademark and copyright laws. The original version of this report can be accessed at https://baseballnewssource.com/2018/03/22/positive-news-coverage-somewhat-unlikely-to-impact-fonar-fonr-stock-price/1925704.html.

About Fonar

Fonar Corporation (Fonar) is engaged in the business of designing, manufacturing, selling and servicing magnetic resonance imaging (MRI) scanners, which utilizes MRI technology for the detection and diagnosis of human disease, abnormalities, other medical conditions and injuries. The Company operates its business through two segments: Medical Equipment segment, and Physician Management and Diagnostic Services segment.

Insider Buying and Selling by Quarter for Fonar (NASDAQ:FONR)

Receive News & Ratings for Fonar Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fonar and related companies with MarketBeat.com's FREE daily email newsletter.

 




Latest News

Ji-Man Choi Receives Another Chance in Milwaukee
Ji-Man Choi Receives Another Chance in Milwaukee
Marlins vs Dodgers sets a 10-year record in MGM sportsbooks
Marlins vs Dodgers sets a 10-year record in MGM sportsbooks
Strikeouts Once Again Plaguing Cubs
Strikeouts Once Again Plaguing Cubs
Atlanta Braves: A Mix of Young and Old
Atlanta Braves: A Mix of Young and Old
Major League Baseball is Back and Astros Favored to Repeat
Major League Baseball is Back and Astros Favored to Repeat
Jim Kaat: Baseball Would Be Helped by Shortening Game to Seven Innings
Jim Kaat: Baseball Would Be Helped by Shortening Game to Seven Innings


Leave a Reply

 
© 2006-2018 BBNS.